Background Helicobacter pylori (H pylori) infection has been implicated in a number of
malignancies and non‐malignant conditions including peptic ulcers, non‐ulcer dyspepsia …

Gastric cancer continues to be an important healthcare problem from a global perspective.
Most of the cases in the Western world are diagnosed at late stages when the treatment is …

Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common
and are associated with an increased risk for gastric cancer. In the absence of guidelines …

Background The combination of pepsinogen, gastrin‐17 and anti‐H. pylori antibodies
serological assays (panel test) is a non‐invasive tool for the diagnosis of atrophic gastritis …

In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

Objectives: We aimed to assess a serological biopsy using five stomach-specific circulating
biomarkers—pepsinogen I (PGI), PGII, PGI/II ratio, anti-Helicobacter pylori (H. pylori) …

Significant progress has been obtained since the III Brazilian Consensus Conference on H.
pylori infection held in 2012, in Bento Gonçalves, Brazil, and justify a fourth meeting to …

Objective International guidelines recommend endoscopic surveillance of premalignant
gastric lesions. However, the diagnostic yield and preventive effect require further study. We …

Several reports of estimates for precancerous conditions for gastric adenocarcinoma can be
found in the current literature. Our aim was to systematically review and estimate the …

Auch wenn nach internationalen, populationsbasierten Studien die Prävalenz der
Helicobacter pylori (H. pylori)-Infektion in den letzten Jahren abgenommen hat, bleibt etwa …